Exchange: NYSE
Industry: Scientific/Tech Instrmnts
Last Trade: 4:00 PM ET 2/9/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.84 | 0.65 | 29.23 |
| EPS, GAAP | 0.81 | 0.83 | -2.41 |
| Consensus Estimate | 0.81 | 0.60 | 35.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.95 | 2.95 | 0.00 |
| EPS, GAAP | 2.83 | 1.94 | 45.88 |
| Consensus Estimate | 2.76 | NA | NA |
| A | Industry Average | |
| P/E (TTM) | 15.89 | 32.80 |
| P/E (Forward) | 14.10 | 17.80 |
| PEG Ratio | 1.06 | 1.59 |
| Price/Sales | 2.41 | 2.58 |
| Beta | 1.54 | 1.91 |
| 2:15 PM | 1/20/2012 | 3rd UPDATE: FDA: More Orange Juice Shipments Negative For Fungicide |
| 9:39 AM | 1/18/2012 | Agilent Initiates Quarterly Dividend Of 10 Cents A Share |
| 2/1/2012 | Don't just ask, "How much inventory?" Ask, "What kind?" (The Motley Fool) |
| 1/25/2012 | Biotech analysts see higher bid for Illumina (MarketWatch.com) |
| 1/18/2012 | Agilent Joins The Great Dividend Chase (A) (24/7 Wall St) |
| 1/9/2012 | At the End of the Day: 1/09/12 (WSJ.com) |
| 1/6/2012 | Let's take a look. (The Motley Fool) |
| 1/4/2012 | Analysts' Picks No Better Than Throwing Darts (SmartMoney.com) |
| 1/3/2012 | UBS analysts are optimistic on the prospect of these undervalued stocks -- do you agree with their bullish sentiment? (The Motley Fool) |
| 12/31/2011 | S&P 500 Companies' Fourth-Quarter Earnings Guidance (Barrons.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
